- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06918353
The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome
Construction and Evaluation of the Severity Assessment Model for AECOPD With Combination of Disease and Syndrome Based on Machine Learning
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Hailong H Zhang, doctor
- Phone Number: +86-0371-66248624
- Email: zhanghailong6@126.com
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
-
Contact:
- Hailong H Zhang, doctor
- Phone Number: +86-0371-66248624
- Email: zhanghailong6@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Meets AECOPD diagnostic criteria.
- Voluntarily participate in the research and sign the consent form
Exclusion Criteria:
- Individuals with severe mental disorders and cognitive impairments who are unable to communicate normally
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
AECOPD Patients
|
Diagnosis and severity grading of AECOPD disease, as well as assessment of traditional Chinese medicine syndromes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Investigation Questionnaire on Influencing Factors of the Severity of AECOPD
Time Frame: 24 hours
|
The influencing factors of the severity of AECOPD were evaluated through clinical investigation questionnaires. Questionnaire Title: Clinical Investigation Questionnaire on Influencing Factors of AECOPD Severity. The questionnaire adopts the scoring method, which is divided into "very unimportant", "not important", "average", "important" and "very important", and the corresponding values are assigned as 1, 2, 3, 4 and 5 respectively.The higher the score is, the more significant the result is. |
24 hours
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Model for AECOPD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Exacerbation of Chronic Obstructive Pulmonary Disease
-
Sir Run Run Shaw HospitalNot yet recruitingAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
Hasselt UniversityTerminatedAcute Exacerbation of COPD | Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseBelgium
-
Ain Shams UniversityNot yet recruitingAcute Exacerbation Chronic Obstructive Pulmonary DiseaseEgypt
-
AstraZenecaCompletedAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
Beijing Chao Yang HospitalCompletedAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
AstraZenecaCompletedAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
Wuhan Union Hospital, ChinaRecruitingAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
Aveiro UniversityFundação para a Ciência e a TecnologiaRecruitingAcute Exacerbation of Chronic Obstructive Pulmonary DiseasePortugal
-
University of MonastirCompletedAcute Exacerbation of Chronic Obstructive Airways DiseaseTunisia
-
Huashan HospitalUnknownMicrobiome | Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
Clinical Trials on Diagnosis and Severity Grading of AECOPD Disease
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Changhai Hospital; Shanxi Province Cancer Hospital and other collaboratorsNot yet recruitingComplication,Postoperative | StomaChina
-
Hannover Medical SchoolRecruitingComplication of Surgical Procedure | Complication,Postoperative | Complication of Anesthesia | Complication of Medical CareGermany
-
Ain Shams UniversityCompleted
-
University Hospital, BordeauxRecruitingParkinson's Disease | Multiple System Atrophy | Progressive Supranuclear Palsy | Parkinsonian SyndromesFrance
-
Hannover Medical SchoolKarolinska Institutet; Helsinki University Central Hospital; University of Leipzig and other collaboratorsRecruitingComplication of Surgical ProcedureGermany
-
NHS National Waiting Times Centre BoardBritish Heart Foundation; University of Glasgow; NHS Greater Clyde and Glasgow; Chief Scientist Office of the Scottish GovernmentActive, not recruitingAngina, Stable | Angina Pectoris, Variant | Microvascular AnginaUnited Kingdom
-
General University Hospital, PragueRecruitingMolecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease SeverityCzechia
-
University Hospital, BordeauxCompletedChronic Pain | Fabry's DiseaseFrance
-
Dr. Rebecca SchuleGerman Research Foundation; German Center for Neurodegenerative Diseases (DZNE)RecruitingSpastic AtaxiaCanada, France, Germany, Italy, Netherlands, Turkey, United Kingdom
-
University of British ColumbiaCompleted